In 2024, there were major advances in inflammatory bowel disease research. Treatment strategies with biologic agents for inflammatory bowel disease matured, and gut microbiota–bacteriophage–host interaction emerged as a new frontier to target.

中文翻译：

---

随着宿主-微生物相互作用的出现，IBD 的生物制剂逐渐成熟


2024 年，炎症性肠病研究取得了重大进展。使用生物制剂治疗炎症性肠病的治疗策略日趋成熟，肠道微生物群-噬菌体-宿主相互作用成为新的靶点。